Latest News
Restaurant software platform Toast (NYSE:TOST) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 24.4% year on year to $1.34 billion. Its non-GAAP profit of $0.24 per share was 30.1% above analysts’ consensus estimates.
Via StockStory · May 9, 2025
Via Benzinga · May 9, 2025
This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.
Via Benzinga · May 9, 2025
D-Wave shares rose after an analyst praised its revenue surge, high-margin system sales, and growing commercial traction in quantum solutions.
Via Benzinga · May 9, 2025
An 80 percent tariff is nearly as stupid as a 145 percent tariff because most trade with China would still stop. Trade might stop at 50 percent.
Via Talk Markets · May 9, 2025
Outdoor lifestyle products brand (NYSE:YETI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.9% year on year to $351.1 million. Its non-GAAP profit of $0.31 per share was 14.6% above analysts’ consensus estimates.
Via StockStory · May 9, 2025
FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and modernize drug approvals.
Via Benzinga · May 9, 2025
Via Benzinga · May 9, 2025
States are suing the federal government after HHS Secretary Robert F. Kennedy Jr. ordered layoffs and agency closures, disrupting critical public health programs nationwide.
Via Benzinga · May 9, 2025
Birkenstock earns praise from analyst for tariff resilience and strong Q2 growth outlook driven by premium positioning and solid global demand.
Via Benzinga · May 9, 2025
Celsius Founder Alex Mashinsky had requested a one-year and one-day term, expressing remorse and a desire to make amends to his family and customers.
Via Stocktwits · May 9, 2025
Via Benzinga · May 9, 2025
Globalstar shares are trading lower by 13.1% during Friday's session. The company reported worse-than-expected Q1 EPS and revenue.
Via Benzinga · May 9, 2025
All it took was two weeks of stocks falling to trigger a consumer panic that would have easily resulted in a recession had things not changed course.
Via Talk Markets · May 9, 2025
XRP (CRYPTO: XRP) is surging as fresh whale accumulation and positive sentiment around the SEC settlement spark renewed interest in the token.
Via Benzinga · May 9, 2025
Needham analyst Bernie McTernan maintained a Buy rating on DraftKings Inc. (NASDAQ:DKNG) and reiterated the $65 price forecast following the first quarter results reported on Thursday.
Via Benzinga · May 9, 2025
The CEO dismissed the impact of Trump tariffs, noting that the company produces a major portion of its goods in the U.S.
Via Stocktwits · May 9, 2025
Via Benzinga · May 9, 2025
U.S. corn export sales week ending May 1st totaled 65 Mil Bu, a full 57 Mil above the pace needed to meet USDA's annual forecast.
Via Talk Markets · May 9, 2025
Via The Motley Fool · May 9, 2025
Wall Street traded slightly lower by midday Friday, as investors adopted a wait-and-see stance ahead of a potential trade breakthrough, with high-stakes negotiations between U.S. officials—led by Treasury Secretary Scott Bessent—and Chinese authorities set to unfold over the weekend.
Via Benzinga · May 9, 2025
EchoStar Corporation (NASDAQ: SATS) reported a loss of 71 cents per share, with quarterly sales of $3.87 billion. SATS stock has gained 56% in the past year.
Via Benzinga · May 9, 2025
Via Benzinga · May 9, 2025
U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states and assets of around $680 billion.
Via Talk Markets · May 9, 2025
The oil market is starting to finally turn around as President Trump’s trade deals may start to come fast and furious.
Via Talk Markets · May 9, 2025
Via Benzinga · May 9, 2025
Via Benzinga · May 9, 2025
Google’s back-to-back discrimination cases have pushed Alphabet’s settlement total to $78 million in just two months.
Via Stocktwits · May 9, 2025
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
Via Benzinga · May 9, 2025
Trade talks are in focus, ahead of negotiations between U.S. and Chinese officials, which will begin in Switzerland this weekend.
Via Talk Markets · May 9, 2025
Lyft stock rises on $1.45B revenue, $750M buyback plan. Needham reiterates hold, Goldman Sachs upgrades to buy with PT of $20. Strong growth despite competition.
Via Benzinga · May 9, 2025